Home Cart 0 Sign in  

[ CAS No. 757239-60-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 757239-60-4
Chemical Structure| 757239-60-4
Structure of 757239-60-4 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 757239-60-4 ]

Related Doc. of [ 757239-60-4 ]

Alternatived Products of [ 757239-60-4 ]
Product Citations

Product Details of [ 757239-60-4 ]

CAS No. :757239-60-4 MDL No. :MFCD11110708
Formula : C13H15NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :VMBHUIMZBSWWCN-UHFFFAOYSA-N
M.W : 249.26 Pubchem ID :45072502
Synonyms :

Calculated chemistry of [ 757239-60-4 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.38
Num. rotatable bonds : 6
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 67.91
TPSA : 55.84 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.93 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.73
Log Po/w (XLOGP3) : 1.25
Log Po/w (WLOGP) : 0.9
Log Po/w (MLOGP) : 1.31
Log Po/w (SILICOS-IT) : 1.3
Consensus Log Po/w : 1.5

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.02
Solubility : 2.36 mg/ml ; 0.00947 mol/l
Class : Soluble
Log S (Ali) : -2.02
Solubility : 2.38 mg/ml ; 0.00953 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.51
Solubility : 0.772 mg/ml ; 0.0031 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.67

Safety of [ 757239-60-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 757239-60-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 757239-60-4 ]

[ 757239-60-4 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 100202-39-9 ]
  • [ 501-53-1 ]
  • [ 757239-60-4 ]
YieldReaction ConditionsOperation in experiment
99% With sodium hydroxide In tetrahydrofuran; water at 0 - 20℃; for 18 h; A round bottomed flask containing methyl azetidine-3-carboxylate hydrochloride(3 g, 20 mmol), THF (30 mL) and H20 (30 mL) was added with an aqueous solution ofNaOH (4 M, 5 mL, 20 mmol) at 0 °C, followed by benzyl chloroformate (2.84 mL, 20 mmol). The reaction was vigorously stirred at room temperature for 18 hours. The reaction mixture was concentrated in vacuo and the residue partitioned between Et20 (100 mL) and H20 (30 mL). The aqueous phase was back-extracted withEt20 (3 x 50 mL), the combined organic phases were dried (Na2SO4) and concentrated in vacuo to give the title compound (5 g, 99percent) as a colourless oil, which was used in subsequent steps without further purification.‘H NMR (400 MHz, CDC13): ö 7.43-7.25 (m, 5 H), 5.10 (s, 2 H), 4.23-4.13 (m, 4 H), 3.74 (s, 3 H), 3.38 (q, J = 7.2 Hz, 1 H).
Reference: [1] Patent: WO2016/177849, 2016, A1, . Location in patent: Page/Page column 74; 75
[2] Patent: US2011/183960, 2011, A1, . Location in patent: Page/Page column 27
  • 2
  • [ 97628-92-7 ]
  • [ 18107-18-1 ]
  • [ 757239-60-4 ]
YieldReaction ConditionsOperation in experiment
96%
Stage #1: at 0℃;
Stage #2: With acetic acid In methanol; hexanes; toluene
1-BENZYLOXYCARBONYL-3-AZETIDINECARBOXYLIC acid (from step (i); 9.3g, 39. 6MMOL) was dissolved in methanol (LOOML) and toluene (100mL), and cooled to 0°C. A solution of 2M trimethylsilyldiazomethane in hexanes was then added dropwise until bubbling had ceased and the yellow colour persisted. Acetic acid was then added dropwise until the yellow colour disappeared. Concentration of the solution yielded the title compound as an oil (9.48G, 38mmol, 96percent). IH NMR (400MHZ, CDC13) : 8 7.36-7. 31 (5H, m), 5.10 (2H, s), 4.19 (4H, D, J7. 8Hz), 3.75 (3H, s), 3.39 (1H, quintet, J 7. 8HZ).
Reference: [1] Patent: WO2004/78750, 2004, A1, . Location in patent: Page 81
  • 3
  • [ 186581-53-3 ]
  • [ 97628-92-7 ]
  • [ 757239-60-4 ]
YieldReaction ConditionsOperation in experiment
98% at 20℃; for 4 h; EXAMPLE 27B; 1-benzyl 3-methylazetidine-1,3-dicarboxylate A solution of Example 27A (4.8 g, 20.3 mmol) in ether (100 ml) was treated with diazomethane (100 ml in ether, 60 mmol) at room temperature for 4 hours. Removal of the volatiles gave Example 27B (4.8 g Yield: 98percent). MS (DCI/NH3) m/z 250 (M+H)+.
Reference: [1] Patent: US2006/229289, 2006, A1, . Location in patent: Page/Page column 19
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;